Cambridge researchers identify molecular ‘on/off’ change in malignant germ cell tumours Research could lead to new medications to turn 'switch' off Cambridge researchers have identified an 'on/off' change in a kind of cancer which typically occurs in the testes and ovaries known as 'malignant germ cell tumours'. The study was published today, august 01, in the journal Cancer Analysis. Malignant germ cell tumours occur in sperm – or egg-forming cells and usually happen in the reproductive organs, the ovaries or testes. The cancerous tumours have emerged in patients of most ages, both in adulthood and childhood. Although many patients prosper after treatment, current chemotherapy treatments can have serious long-term side effects, including hearing loss and harm to the kidneys, lungs and bone marrow.‘Applying the over-the-wire strategy to deliver an IVC filter is a substantial development, having a technique we often use during endovascular techniques. It gives a physician more control to position the filtration system during delivery accurately,’ said Dr. Munier Nazzal, Chief of Vascular and Endovascular Surgery at the University of Toledo. ‘Among retrievable IVC filter systems, finding the right combination of features that produce a filtration system easy to provide, provide stability in the IVC, and make it easy to retrieve, is a key balance that few styles have attained.S.’ Argon Medical Products, Inc. Additionally, the business recently received approval from Health Canada and began advertising the product in that geography recently. In the United States alone, PE is the third leading reason behind death among hospitalized individuals.